Obesity Trial, Recruiting (NCT06292728)

Obesity Trial, Recruiting NCT06292728 Sponsor: ENDOPLY Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06292728 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your Body Mass Index (BMI) is between 30 and 40, meaning you are classified as moderately obese
You are older than 18 and younger than 60 years old
You have tried multiple diets in the past without lasting success

Who may not be able to join:

You have a condition affecting how your food pipe (oesophagus) moves food, such as achalasia or similar disorders
You have severe inflammation of the food pipe (oesophagus)
You have an ulcer in your stomach or the upper part of your small intestine
You have heart disease or high blood pressure that is currently not being treated
You have serious lung, kidney, or liver disease, or any form of cancer
You are currently pregnant, planning to become pregnant, or have been pregnant in recent months
You have previously had weight-loss surgery or a weight-loss procedure done by camera/scope
You are currently taking part in another medical research study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jerome Dargent, MD, CEO, chief executive

Phone: 0033681472286

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06292728

Sponsor: ENDOPLY

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 0033681472286

More information: https://clinicaltrials.gov/study/NCT06292728

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your Body Mass Index (BMI) is between 30 and 40, meaning you are classified as moderately obese
You are older than 18 and younger than 60 years old
You have tried multiple diets in the past without lasting success

Who may not be able to join:

You have a condition affecting how your food pipe (oesophagus) moves food, such as achalasia or similar disorders
You have severe inflammation of the food pipe (oesophagus)
You have an ulcer in your stomach or the upper part of your small intestine
You have heart disease or high blood pressure that is currently not being treated
You have serious lung, kidney, or liver disease, or any form of cancer
You are currently pregnant, planning to become pregnant, or have been pregnant in recent months
You have previously had weight-loss surgery or a weight-loss procedure done by camera/scope
You are currently taking part in another medical research study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ENDOPLY

Registry

ClinicalTrials.gov

Start date

9 January 2022

Est. completion

1 October 2025

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Time of duration of the ENDOPLY System study procedure; Number of ligatures placed by ENDOPLY System study procedure; Gastric perforation events; Gastrointestinal bleeding events; Initial weight-loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov